Press Releases

2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

2005 Press Releases

Listed below are all of the QLT press releases available for the year you have selected.

December 22	QLT Announces Departure of Chief Business Officer	PDF version
December 14	QLT Announces Partial Result in Eligard® Patent Litigation	PDF version
December 13	QLT Announces TSX Approval to Increase its Share Repurchase Program to $100 Million	PDF version
December 7	QLT Announces Repositioning and Streamlining for Future Growth	PDF version
December 5	QLT to Host Conference Call to Discuss Strategic Update	PDF version
October 27	QLT Announces Q3 Results for 2005	PDF version
October 18	QLT Announces Visudyne Sales for Third Quarter of 2005	PDF version
September 25	President and CEO Paul Hastings steps down	PDF version
September 20	QLT Announces Two Year Results of Visudyne® in Occult (VIO) Trial	PDF version
August 9	QLT Appoints Cameron Nelson as Vice President, Finance and Chief Financial Officer	PDF version
July 28	QLT Announces Q2 Results for 2005 and Revises Guidance	PDF version
July 13	QLT Announces Visudyne® Sales for Second Quarter of 2005	PDF version
July 7	ACZONE™ Gel is Approved for the Treatment of Acne by the FDA	PDF version
July 5	QLT Acquires Full Rights to ACZONE ™, By Mutual Agreement with Astellas	PDF version
May 2	QLT Announces TSX Approval of US $50 Million Share Repurchase Program	PDF version
April 28	QLT Announces Q1 Results for 2005 and Reiterates Guidance	PDF version
April 21	QLT Announces Visudyne Sales for First Quarter of 2005	PDF version
April 11	QLT Announces Senior Management Changes	PDF version
February 28	Sosei Files Japan Marketing Authorization Application for Prostate Cancer Drug SOT-375	PDF version
February 23	QLT Announces 2004 Results and Outlook for 2005	PDF version
February 18	Aczone Data Demonstrates Reduction in Number and Severity of Acne Lesions	PDF version
February 17	Commercial Availability of QLT’s Eligard® 6-Month Formulation Brings New Treatment Option for Advanced Prostate Cancer	PDF version
January 26	QLT Announces Favorable Court Decision in Massachusetts Eye and Ear Infirmary (MEEI) Patent Litigation	PDF version
January 26	QLT Announces Eligard® Sales For 2004	PDF version
January 20	QLT Announces Visudyne® Sales for Fourth Quarter and Fiscal Year 2004	PDF version

Visudyne® is a registered trademark of Novartis AG

Vancouver Web Design by Graphically Speaking